EBR Systems Receives CE Mark for Its Wireless Cardiac Pacing System

EBR Systems’ WiSE Technology is the world’s only wireless endocardial pacing system for cardiac resynchronization therapy, said the company in a press release.

EBR Systems, a leading innovator in wireless heart stimulation, has received European CE Mark for its WiSE (Wireless Stimulation Endocardially) Technology.

According to the company, EBR Systems’ WiSE Technology is the world’s only wireless endocardial pacing system for cardiac resynchronization therapy (CRT).

Kokilaben Hospital Reaches a Milestone With 5,000 Successful Pediatric Cardiac Surgeries
The Children's Heart Center is said to be the only integrated facility for treating congenital heart disease in Mumbai and Western India.

CE Mark approval gives EBR Systems the ability to train and educate physicians in the European Union on the use of the WiSE System. It will help more patients to benefit from this innovative therapy.

Preliminary results of the recently completed SELECT-LV study were presented in mid-May by Mt. Sinai Hospital cardiologist and Professor of Medicine Vivek Reddy, M.D., at the Heart Rhythm Society Scientific Sessions in Boston.

The results were highly positive. “A growing body of evidence strongly suggests EBR’s WiSE Technology can benefit patients who have failed conventional cardiac resynchronization implants,” said EBR Systems CEO Allan Will. “We look forward to working with leaders in the European clinical community to further characterize the benefits of wireless endocardial pacing.”

35 Minutes Of CPR For Out-Of-Hospital Cardiac Arrest can Help Achieve Favorable Results
The study in more than 17 000 patients found that nearly all survivals were achieved within 35 minutes and longer CPR achieved little benefit.

The WiSE Technology is leadless, completely eliminating the want for a pacing wire in the left ventricle. The technology consists of a tiny electrode implanted in the left ventricle. With every heartbeat it gets a synchronized ultrasound signal from a small transmitter placed between two ribs. Those sound waves are converted to electrical energy, providing cardiac pacing.

Doctors are in Favor of Traditional Cardiac Surgery Despite Better Alternative
The chances of a re-surgery significantly comes down to less than 3% cases and less than 5% cases in 10 and 20 years time respectively if the surgeon opts for BIMA grafting.

Source-Medindia

Biotronik�s BioMonitor 2 Implantable Wireless Cardiac Monitor Receives CE Approval
The device is designed for highly accurate and reliable long-term continuous remote monitoring of patients with atrial fibrillation, syncope and bradycardia.